【Introduction】
Product Name: Human CD69 Antibody (Genefrontier patent anti-CD69, Research Use)
Catalog Number: NBR-0467
Target Name: CD69
Trade Name: Genefrontier patent anti-CD69
Antibody Drug Description: The drug is a recombinant fully human anti-CD69 monoclonal antibody, being developed by genefrontier.
【Description】
Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS:N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG
【Gene Information】
Gene Name: CD69
Synonyms: CLEC2C; CD69 Antigen (P60; Early T-Cell Activation Antigen); Early T-Cell Activation Antigen P60; Leukocyte Surface Antigen Leu-23; Early Activation Antigen CD69; BL-AC/P26; GP32/28
Target Description: Involved in lymphocyte proliferation and functions as a signal transmitting receptor in lymphocytes, natural killer (NK) cells, and platelets.
Ensembl: ENSG00000110848
Uniprot: Q07108